focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeiger Counter Regulatory News (GCL)

Share Price Information for Geiger Counter (GCL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 53.00
Bid: 52.00
Ask: 54.00
Change: 0.50 (0.95%)
Spread: 2.00 (3.846%)
Open: 52.50
High: 53.00
Low: 51.50
Prev. Close: 52.50
GCL Live PriceLast checked at -
Geiger Counter is an Investment Trust

To deliver attractive returns to shareholders principally in the form of capital growth, through investment in companies involved in the exploration, development and production of uranium to supply the nuclear power industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

9 Mar 2022 15:15

RNS Number : 2297E
Geiger Counter Ltd
09 March 2022
 

GEIGER COUNTER LIMITED - AGM

Geiger Counter Limited held it's Annual General Meeting on the 9 March 2022 at Ordnance House, 31 Pier Road, St Helier, Jersey.

The Chairman of the AGM is pleased to report that the following ordinary resolutions, each as listed in the notice of annual general meeting distributed in December 2021, were passed by the members:

1. To receive and adopt the Report of the Directors and the financial statements of the Company for the year ended 30 September 2021, together with the auditor's report thereon.

§ 8 votes in favour of the resolution representing 11,231,684 shares;

§ No votes against;

§ 3 votes withheld representing 27,079 shares;

§ 1 which the Chairman has been given discretion representing 100,000 shares.

 

2. That KPMG Channel Islands Limited, Chartered Accountants, be re-appointed as Auditor and that the Directors be authorised to determine their remuneration.

§ 8 votes in favour of the resolution representing 11,234,441 shares;

§ No votes against;

§ 3 votes withheld representing 24,322 shares;

§ 1 which the Chairman has been given discretion representing 100,000 shares.

 

3. To approve the Directors' Remuneration Report for the year ended 30 September 2021.

§ 8 votes in favour of the resolution representing 11,157,837 shares;

§ 3 votes against the resolution representing 69,525 shares;

§ 3 votes withheld representing 31,401 shares;

§ 1 which the Chairman has been given discretion representing 100,000 shares.

 

4. That, pursuant to article 45.1 of the Articles of Association of the Company ("the Articles"), the Directors shall extend the life of the Company from the fifteenth anniversary of the First Closing Date until the next annual general meeting of the Company, when a further extension will be sought.

§ 8 votes in favour of the resolution representing 11,241,058 shares;

§ No votes against;

§ 2 votes withheld representing 17,705 shares;

§ 1 which the Chairman has been given discretion representing 100,000 shares.

 

5. That ordinary shares (the "new shares") may be issued by the Company in one or more tranches over a period from the date of the AGM to the next AGM of the Company, at a premium over the net asset value per share and that such issue of new shares is approved in accordance with article 6.1 of the Company's Articles.

§ 8 votes in favour of the resolution representing 10,819,615 shares;

§ 3 votes against the resolution representing 404,826 shares;

§ 3 votes withheld representing 34,322 shares;

§ 1 which the Chairman has been given discretion representing 100,000 shares.

 

6. To re-elect Gary Clark, a Director retiring by rotation, as a Director.

§ 8 votes in favour of the resolution representing 11,230,119 shares;

§ No votes against;

§ 3 votes withheld representing 28,644 shares;

§ 1 which the Chairman has been given discretion representing 100,000 shares.

 

7. To re-elect James Leahy, a Director retiring by rotation, as a Director.

§ 8 votes in favour of the resolution representing 11,230,119 shares;

§ No votes against;

§ 3 votes withheld representing 28,644 shares;

§ 1 which the Chairman has been given discretion representing 100,000 shares.

 

8. To re-elect Professor Ian Reeves CBE as a Director.

§ 8 votes in favour of the resolution representing 11,230,119 shares;

§ No votes against;

§ 3 votes withheld representing 28,644 shares;

§ 1 which the Chairman has been given discretion representing 100,000 shares.

The Chairman is pleased to report that the following special resolution, as listed in the notice of Annual General Meeting distributed in December 2021, was passed by the members:

9. That the Company be and is hereby generally and unconditionally authorised, pursuant to and in accordance with article 57 of the Companies (Jersey) Law, 1991 (as amended) (the "Law") to make market purchases of its own ordinary shares in the capital of the Company (the "ordinary shares") on such terms and in such manner as the Directors of the Company shall from time to time determine, provided that:

(a) the maximum aggregate number of ordinary shares hereby authorised to be purchased shall be such number as represents 14.99 per cent of the aggregate number of ordinary shares in issue as at 9 March 2021;

(b) the minimum price which may be paid for an ordinary share shall be 1p;

(c) the maximum price exclusive of any expenses which may be paid for an ordinary share is an amount equal to the higher of 5 per cent above the average of the middle market quotations for an ordinary share as derived from the London Stock Exchange for the five business days immediately preceding the date on which such ordinary share is contracted to be purchased;

(d) the authority hereby conferred shall expire on 18 months from the date of this Special Resolution, unless previously revoked, varied or renewed by the Company in general meeting;

(e) the Company may at any time prior to the expiry of such authority make a contract or contracts to purchase ordinary shares under such authority which will or might be completed or executed wholly or partly after the expiration of such authority and may make a purchase of ordinary shares in pursuance of any such contract or contracts;

(f) the Directors of the Company provide a statement of solvency in accordance with articles 53-57 of the Law; and

(g) such shares are acquired for cancellation.

§ 8 votes in favour of the resolution representing 11,234,441 shares;

§ No votes against;

§ 3 votes withheld representing 24,322 shares;

§ 1 which the Chairman has been given discretion representing 100,000 shares.

 

 

The Chairman announced his intention to resign at the board meeting, after the AGM, with effect from 9 March 2022.

 

Mr Baird has been the Chairman of the Company since 2006 and the Board wish to record their appreciation for his contribution to the Company over that time.

 

Overall the Board remains very positive about the scale of opportunity for the Company and sees an attractive investment environment for uranium. Accordingly, the Company is considering an equity raise to fund further investments. Should the Company decide to proceed with an equity raise, an announcement with details will be made in due course.

 

 

For more information, please contact:

Craig Cleland

CQS (UK) LLP

Tel: +44 (0) 2072015368

 

Jessica Riley

R&H Fund Services (Jersey) Limited

Tel: +44 (0) 1534 825236

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMUKSSRUSUORAR
Date   Source Headline
15th May 20241:55 pmRNSNet Asset Value(s)
14th May 202412:15 pmRNSNet Asset Value(s)
13th May 20241:45 pmRNSNet Asset Value(s)
10th May 20244:05 pmRNSNet Asset Value(s)
10th May 20248:00 amRNSNet Asset Value(s)
9th May 202411:15 amRNSExercise of outstanding Subscription Share Rights
8th May 20245:15 pmRNSNet Asset Value(s)
8th May 20244:45 pmRNSCorrection to Diluted Net Asset Value
7th May 20245:30 pmRNSNet Asset Value(s)
7th May 20241:30 pmRNSNotification in regard to Subscription Rights
7th May 20241:15 pmRNSResult of subscription rights exercise
3rd May 20242:20 pmRNSNet Asset Value(s)
2nd May 20242:45 pmRNSNet Asset Value(s)
1st May 20243:35 pmRNSNet Asset Value(s)
30th Apr 20243:30 pmRNSNet Asset Value(s)
30th Apr 20242:00 pmRNSShare Buyback
29th Apr 202412:45 pmRNSNet Asset Value(s)
29th Apr 202412:30 pmRNSShare Buyback
26th Apr 20242:15 pmRNSGCL MONTHLY FACT SHEET MARCH 2024
26th Apr 202412:15 pmRNSNet Asset Value(s)
26th Apr 202412:00 pmRNSShare Buyback
25th Apr 20242:45 pmRNSNet Asset Value(s)
25th Apr 20242:00 pmRNSShare Buyback
24th Apr 20242:40 pmRNSNet Asset Value(s)
24th Apr 20241:30 pmRNSShare Buyback
23rd Apr 20243:30 pmRNSNet Asset Value(s)
23rd Apr 20241:45 pmRNSShare Buyback
22nd Apr 20243:35 pmRNSNet Asset Value(s)
22nd Apr 20241:30 pmRNSShare Buyback
19th Apr 20242:35 pmRNSNet Asset Value(s)
18th Apr 20241:35 pmRNSNet Asset Value(s)
17th Apr 202412:20 pmRNSNet Asset Value(s)
16th Apr 20245:20 pmRNSNet Asset Value(s)
15th Apr 202412:50 pmRNSNet Asset Value(s)
12th Apr 20241:35 pmRNSNet Asset Value(s)
11th Apr 20241:15 pmRNSNet Asset Value(s)
10th Apr 20243:40 pmRNSNet Asset Value(s)
9th Apr 20241:25 pmRNSNet Asset Value(s)
8th Apr 20241:10 pmRNSNet Asset Value(s)
5th Apr 20242:05 pmRNSNet Asset Value(s)
4th Apr 20241:10 pmRNSNet Asset Value(s)
3rd Apr 20242:40 pmRNSNet Asset Value(s)
3rd Apr 20249:00 amRNSInvestment Manager Acquisition
2nd Apr 20243:50 pmRNSNet Asset Value(s)
28th Mar 20241:50 pmRNSNet Asset Value(s)
27th Mar 20241:00 pmRNSNet Asset Value(s)
27th Mar 20249:33 amRNSNotification to Shareholders - Subscription Rights
26th Mar 20242:55 pmRNSNet Asset Value(s)
25th Mar 20241:00 pmRNSNet Asset Value(s)
22nd Mar 20244:45 pmRNSPotential listing on the London Stock Exchange

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.